As the amount of omics data — including transcriptomics, genomics, and epigenomics — grows at an unprecedented pace, so does the challenge of making sense of it all. Artificial intelligence (AI) and automated analysis tools are now making it easier to sift through complex omics data to find patterns that point to new drug targets, biomarkers, and therapeutic strategies. In this webinar, Alex Zhavoronkov will discuss how his team uses generative AI and automation to streamline target discovery and advance aging research.
Topics to be covered:
- Identifying novel therapeutic targets and biomarkers with generative AI
- Integrating multiomics data in aging and disease research
- Using fully automated laboratories for high throughput drug discovery
Tuesday, August 5th, 2025 | 11:00 AM – 12:00 PM Eastern Time
This webinar will be available to view live and on demand.
Speaker
Alex Zhavoronkov, PhD
Founder and CEO
Insilico Medicine
